Allecra Therapeutics Overview
- Year Founded
-
2013
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Liquidation
Allecra Therapeutics General Information
Description
Developer of novel antibiotics designed to combat gram-negative bacterial infections. The company's antibiotics target multidrug-resistant pathogens and address emerging resistance mechanisms, providing effective therapy for patients with difficult-to-treat conditions, enabling healthcare providers to efficiently cure bacterial illnesses and improve patient outcomes.
Contact Information
Website
www.allecra.comCorporate Office
- Im Kränzliacker 9
- 79576 Weil am Rhein
- Germany
Corporate Office
- Im Kränzliacker 9
- 79576 Weil am Rhein
- Germany
Allecra Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Bankruptcy: Liquidation | 27-May-2025 | Completed | Bankruptcy: Liquidation | |||
| 4. Later Stage VC (Series C) | 23-Aug-2018 | Completed | Clinical Trials - Phase 3 | |||
| 3. Early Stage VC | 04-Dec-2017 | Completed | Clinical Trials - Phase 3 | |||
| 2. Early Stage VC (Series B) | 20-May-2016 | $25M | $44.4M | Completed | Clinical Trials - Phase 3 | |
| 1. Early Stage VC (Series A) | 18-Apr-2013 | $19.4M | $19.4M | Completed | Startup |
Allecra Therapeutics Comparisons
Industry
Financing
Details
Allecra Therapeutics Competitors (45)
One of Allecra Therapeutics’s 45 competitors is Nosopharm, a Formerly VC-backed company based in Lyon, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nosopharm | Formerly VC-backed | Lyon, France | ||||
| Combioxin | Accelerator/Incubator Backed | Lausanne, Switzerland | ||||
| NovaBiotics | Venture Capital-Backed | Aberdeen, United Kingdom | ||||
| Redbiotec | Venture Capital-Backed | Schlieren, Switzerland | ||||
| Gangagen Biotechnologies | Venture Capital-Backed | Bangalore, India |
Allecra Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Allecra Therapeutics Patents
Allecra Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-201408649-D0 | Method | Inactive | 15-May-2014 | ||
| US-20170101421-A1 | Method | Active | 15-May-2014 | ||
| WO-2015173378-A2 | Method | Inactive | 15-May-2014 | ||
| EP-3143028-A2 | Method for preparing penams | Active | 15-May-2014 | ||
| EP-3143028-B1 | Method for preparing penams | Active | 15-May-2014 | C07D499/87 |
Allecra Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Allecra Therapeutics FAQs
-
When was Allecra Therapeutics founded?
Allecra Therapeutics was founded in 2013.
-
Where is Allecra Therapeutics headquartered?
Allecra Therapeutics is headquartered in Weil am Rhein, Germany.
-
What is the size of Allecra Therapeutics?
Allecra Therapeutics has 7 total employees.
-
What industry is Allecra Therapeutics in?
Allecra Therapeutics’s primary industry is Drug Discovery.
-
Is Allecra Therapeutics a private or public company?
Allecra Therapeutics is a Private company.
-
What is Allecra Therapeutics’s current revenue?
The current revenue for Allecra Therapeutics is .
-
How much funding has Allecra Therapeutics raised over time?
Allecra Therapeutics has raised $71.2M.
-
Who are Allecra Therapeutics’s competitors?
Nosopharm, Combioxin, NovaBiotics, Redbiotec, and Gangagen Biotechnologies are some of the 45 competitors of Allecra Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
